Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report.
Curr Drug Saf
; 19(2): 306-308, 2024.
Article
in En
| MEDLINE
| ID: mdl-37317919
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Breast Neoplasms
/
Dermatomyositis
/
COVID-19
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Curr Drug Saf
Year:
2024
Document type:
Article
Affiliation country:
Tunisia